2 ms·
> One of the key barriers to the widespread adoption of microfluidic technology outside of specialized research laboratories (e.g. in clinical settings) is that
by kube-system 4y ago
> One of the key barriers to the widespread adoption of microfluidic technology outside of specialized research laboratories (e.g. in clinical settings) is that microfluidic devices are often complex to operate.
If their goal is to make something for clinical applications, having an unexpectedly non-working connection could be a problem. Non-"standard" RJ45 and DB9 connections are notorious for confusing end users.